Home Biosimilar Antibodies Protein Tyrosine Kinase VEGFR antibody Ranibizumab (Anti-VEGFA) For research use only.
Not for use in humans.

Ranibizumab (Anti-VEGFA)

Synonyms: Lucentis

Ranibizumab (Anti-VEGFA) is a recombinant humanized IgG1 monoclonal antibody fragment that inhibits (VEGF-A) and degrades angiogenesis throughout the body and in the eye also interrupts the interaction of VEGF with its receptors, and thus prevents the subsequent growth of new blood vessels.

Ranibizumab (Anti-VEGFA)

Purity & Quality Control

Batch: A230501 Purity: 99% Protein concentration: 3.61mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective VEGFR Inhibitors

Biological Activity

Description Ranibizumab (Anti-VEGFA) is a recombinant humanized IgG1 monoclonal antibody fragment that inhibits (VEGF-A) and degrades angiogenesis throughout the body and in the eye also interrupts the interaction of VEGF with its receptors, and thus prevents the subsequent growth of new blood vessels.

Product Details

CAS No. 347396-82-1
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ranibizumab (Anti-VEGFA) | Ranibizumab (Anti-VEGFA) supplier | purchase Ranibizumab (Anti-VEGFA) | Ranibizumab (Anti-VEGFA) cost | Ranibizumab (Anti-VEGFA) manufacturer | order Ranibizumab (Anti-VEGFA) | Ranibizumab (Anti-VEGFA) distributor